
Diabetes Dialogues
Welcome to the conversation…. Brought to you by Dexcom, the Diabetes Dialogues podcast explores new perspectives and discussions from expert healthcare practitioners in the field of diabetes. In each episode, we will investigate topics from across the spectrum of diabetes care – tune in to discover dialogues that will educate, inspire, and empower.
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.
Diabetes Dialogues
Glucose Alerts best practice with Dr. Emma Wilmot associate professor at the University of Nottingham and consultant diabetologist in Derby.
Dr. Emma Wilmot associate professor at the University of Nottingham, and consultant diabetologist in Derby talks to Adam about best practice for setting the different CGM glucose alerts to best support people living with diabetes. Including how to set actionable alerts to support people in day to day life to ensure smoother glucose levels avoiding hypoglyceamia and re-bound hyperglyceamia events.
With;
Dr Emma Wilmot MB ChB BSc (hons) PhD FRCP , Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust , Honorary (Clinical) Associate Professor, University of Nottingham, Founder, Diabetes Technology Network
Urgent low soon alert available with Dexcom G6 and G7 only. Delay 1st High Alert available with Dexcom ONE+ and G7 only.
MAT-4784
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.
All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.
Further CPD accredited education can be found on the Dexcom Education Hub